• English
  • 简体中文
Login Register
Current Location: Home > Drug Registration and Acceptance subscription Help
-
-
-
Visualized Analysis Export Evaluation Conclusion Evaluation Progress
Acceptance No. Drug Name Active Ingredient Dosage Form Classification Submission Acceptance Date Manufacturers Manufacturers Review Status Status Date View
JYHZ2100750 乙磺酸尼达尼布软胶囊 nintedanib esylate Soft capsules Chemical Drugs(5.1) License Renew 2021-12-31 view
JYHZ2100749 乙磺酸尼达尼布软胶囊 nintedanib esylate Soft capsules Chemical Drugs(5.1) License Renew 2021-12-31 view
JYHB2400549 乙磺酸尼达尼布软胶囊 nintedanib esylate Soft capsules Chemical Drugs Supplementary Application 2024-10-15 view
JYHB2400548 乙磺酸尼达尼布软胶囊 nintedanib esylate Soft capsules Chemical Drugs Supplementary Application 2024-10-15 view
JYHB2400482 乙磺酸尼达尼布软胶囊 nintedanib esylate Soft capsules Chemical Drugs Supplementary Application 2024-09-04 view
JYHB2400481 乙磺酸尼达尼布软胶囊 nintedanib esylate Soft capsules Chemical Drugs Supplementary Application 2024-09-04 view
JYHB2200573 乙磺酸尼达尼布软胶囊 nintedanib esylate Soft capsules Chemical Drugs Supplementary Application 2022-10-25 view
JYHB2200572 乙磺酸尼达尼布软胶囊 nintedanib esylate Soft capsules Chemical Drugs Supplementary Application 2022-10-25 view
JYHB2100109 乙磺酸尼达尼布软胶囊 nintedanib esylate Soft capsules Chemical Drugs Supplementary Application 2021-01-30 Certificate Issued 2021-03-08 view
JYHB2100108 乙磺酸尼达尼布软胶囊 nintedanib esylate Soft capsules Chemical Drugs Supplementary Application 2021-01-30 Certificate Issued 2021-03-08 view
JYHB1901348 乙磺酸尼达尼布软胶囊 nintedanib esylate Soft capsules Chemical Drugs Supplementary Application 2019-11-06 勃林格殷格翰(中国)投资有限公司 Boehringer Ingelheim (China) Investment Co Ltd Filed 2019-11-21 view
JYHB1901347 乙磺酸尼达尼布软胶囊 nintedanib esylate Soft capsules Chemical Drugs Supplementary Application 2019-11-06 勃林格殷格翰(中国)投资有限公司 Boehringer Ingelheim (China) Investment Co Ltd Filed 2019-11-21 view
JYHB1801430 乙磺酸尼达尼布软胶囊 nintedanib esylate Soft capsules Chemical Drugs Supplementary Application 2018-12-17 勃林格殷格翰(中国)投资有限公司 Boehringer Ingelheim (China) Investment Co Ltd Certificate Issued 2019-02-26 view
JYHB1801429 乙磺酸尼达尼布软胶囊 nintedanib esylate Soft capsules Chemical Drugs Supplementary Application 2018-12-17 勃林格殷格翰(中国)投资有限公司 Boehringer Ingelheim (China) Investment Co Ltd Certificate Issued 2019-02-26 view
JYHB1801222 乙磺酸尼达尼布软胶囊 nintedanib esylate Soft capsules Chemical Drugs Supplementary Application 2018-10-15 勃林格殷格翰(中国)投资有限公司 Boehringer Ingelheim (China) Investment Co Ltd Filed 2018-10-22 view
JYHB1801221 乙磺酸尼达尼布软胶囊 nintedanib esylate Soft capsules Chemical Drugs Supplementary Application 2018-10-15 勃林格殷格翰(中国)投资有限公司 Boehringer Ingelheim (China) Investment Co Ltd Filed 2018-10-22 view
JYHB1800991 乙磺酸尼达尼布软胶囊 nintedanib esylate Soft capsules Chemical Drugs Supplementary Application 2018-08-17 勃林格殷格翰(中国)投资有限公司 Boehringer Ingelheim (China) Investment Co Ltd Filed 2018-08-22 view
JYHB1800990 乙磺酸尼达尼布软胶囊 nintedanib esylate Soft capsules Chemical Drugs Supplementary Application 2018-08-17 勃林格殷格翰(中国)投资有限公司 Boehringer Ingelheim (China) Investment Co Ltd Filed 2018-08-22 view
JYHB1800933 尼达尼布软胶囊 nintedanib Soft capsules Chemical Drugs Supplementary Application 2018-08-15 勃林格殷格翰(中国)投资有限公司 Boehringer Ingelheim (China) Investment Co Ltd Certificate Issued 2018-10-22 view
JYHB1800932 尼达尼布软胶囊 nintedanib Soft capsules Chemical Drugs Supplementary Application 2018-08-15 勃林格殷格翰(中国)投资有限公司 Boehringer Ingelheim (China) Investment Co Ltd Certificate Issued 2018-10-22 view